Skip to main content

Ramipril (International)

Note: In some countries, this medicine may only be approved for veterinary use.

In the US, Ramipril (ramipril systemic) is a member of the drug class Angiotensin Converting Enzyme Inhibitors and is used to treat Cardiovascular Risk Reduction, Diabetic Kidney Disease, Heart Attack, Heart Failure, High Blood Pressure and Left Ventricular Dysfunction.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C09AA05

CAS registry number (Chemical Abstracts Service)

0087333-19-5

Chemical Formula

C23-H32-N2-O5

Molecular Weight

417

Therapeutic Categories

Antihypertensive agent

Treatment of coronary heart disease

Treatment of heart failure

ACE inhibitor (angiotensin-converting enzyme inhibitor)

Chemical Name

Cyclopenta[b]pyrrole-2-carboxylic acid, 1-[2-[[1-(etoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydro-, [2S-[1[R*(R*)],2α,3aβ,6aβ]]-

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs